Indication
Temozolomide
2 clinical trials
2 products
Clinical trial
Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent GlioblastomaStatus: Recruiting, Estimated PCD: 2025-07-01
Product
6-mercaptopurineClinical trial
A Phase 2 Clinical Trial of Neoadjuvant Camrelizumab Plus Apatinib and Temozolomide in High Risk Clinical Stage Ⅱ-Ⅲ Acral MelanomaStatus: Recruiting, Estimated PCD: 2024-12-31
Product
Camrelizumab